What are the treatment options for a patient with excess tearing (epiphora)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Excess Tearing (Epiphora)

Begin by treating reflex tearing from ocular surface disease with lubricants and anti-inflammatory therapy before considering any anatomical interventions, as this resolves the majority of cases and prevents unnecessary surgery. 1

Diagnostic Framework

The critical first step is distinguishing between two fundamentally different mechanisms 2:

  • Reflex tearing (hypersecretion): Excessive tear production triggered by ocular surface irritation, dry eye, or meibomian gland dysfunction 1, 2
  • True epiphora (drainage failure): Mechanical obstruction or lacrimal pump failure preventing normal tear drainage 2, 3

Key Clinical Clues

Reflex tearing indicators 1:

  • Bilateral presentation
  • Associated ocular surface symptoms (burning, foreign body sensation)
  • Positive dry eye testing (reduced tear break-up time, Schirmer test abnormalities)
  • Patent lacrimal system on irrigation

Anatomical obstruction indicators 3:

  • Unilateral presentation (especially in men, older patients)
  • Lower lid malposition (39.5% of male cases)
  • Punctal stenosis (more common in younger women, 34.6%)
  • Nasolacrimal duct obstruction (29% of referred cases)

Treatment Algorithm

Step 1: Optimize Ocular Surface (First-Line for All Patients)

Initiate lubricant therapy 1:

  • Carboxymethylcellulose 0.5-1%, carmellose sodium, or hyaluronic acid drops during the day
  • Lipid-containing drops if meibomian gland dysfunction is present
  • Petrolatum ointment at bedtime, particularly if nocturnal lagophthalmos exists

Add anti-inflammatory treatment for underlying dry eye 1:

  • Topical cyclosporine 0.05% or lifitegrast for chronic dry eye disease 4
  • Short-term low-dose topical corticosteroids (loteprednol etabonate 0.5% or fluorometholone) for 2-4 weeks to suppress inflammation 4, 5
  • Monitor for steroid-induced IOP elevation and cataract formation 4

Recent evidence for unexplained epiphora 5:

  • Combined therapy with loteprednol etabonate 0.5% twice daily for 10 days plus nepafenac 0.3% once daily for 1 month significantly reduced tear meniscus measurements and Munk epiphora scores
  • This approach is particularly valuable when no clear anatomical cause is identified

Step 2: Address Anatomical Abnormalities (Only After Surface Optimization)

Correct eyelid malposition 1, 3:

  • Lower lid laxity repair for ectropion/entropion (33.3% of cases)
  • This is especially common in older men

Manage punctal stenosis 1, 3:

  • Punctal dilation or surgical punctoplasty
  • More prevalent in women (34.6% vs 22.4% in men)

Step 3: Lacrimal Drainage Surgery (Last Resort)

Dacryocystorhinostomy (DCR) for confirmed nasolacrimal obstruction 6:

  • External DCR remains the gold standard
  • Powered endoscopic DCR shows comparable outcomes
  • Only proceed after optimizing ocular surface and correcting anatomical issues 1

Critical Pitfalls to Avoid

Do not perform premature surgical intervention 1:

  • Many cases of apparent "obstruction" are actually reflex tearing that resolves with medical management
  • Always optimize the ocular surface first

Beware of paradoxical epiphora from punctal plugs 4, 1:

  • Punctal occlusion for dry eye can cause overflow tearing
  • Use cautious trial occlusion before permanent closure
  • 56% of silicone plugs are retained at 2 years, but spontaneous loss can lead to canalicular stenosis (34% at 2 years) 4

Consider malignancy in atypical presentations 7:

  • Chronic unilateral epiphora, especially in older patients, warrants thorough evaluation
  • Lacrimal sac squamous cell carcinoma can masquerade as simple nasolacrimal obstruction
  • Biopsy any abnormal tissue encountered during surgery

Recognize multifactorial etiology 3:

  • 22% of epiphora cases have multiple contributing factors
  • Address all identified causes sequentially for optimal results

Special Considerations

Gender and age differences 3:

  • Women present younger with punctal stenosis and nasolacrimal obstruction, often unilaterally
  • Men present older with eyelid laxity as the predominant cause

Avoid punctal plugs in inflammatory conditions 4:

  • Contraindicated in rosacea conjunctivitis and allergic conjunctivitis
  • May exacerbate symptoms by retaining inflammatory mediators

References

Guideline

Treatment of Painless Epiphora

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Basic diagnostics of tear duct diseases].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2008

Research

The Etiology of Epiphora: A Multifactorial Issue.

Seminars in ophthalmology, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Epiphora: an evidence based approach to the 12 minute consultation.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.